You just read:

New Biologics Must Show Improvements in Efficacy, Safety and Cost-Benefit Compared with Currently Available Agents for Inclusion on Formularies in Argentina, Brazil and Mexico

News provided by

Decision Resources

Dec 19, 2013, 08:00 ET